№ files_lp_3_process_9_71419
File format: docx
Character count: 5250
File size: 17 KB
Structured database search strategy detailing controlled vocabulary and keyword combinations used in Ovid MEDLINE to retrieve literature on cutaneous lupus erythematosus and related plant-based or antimalarial treatments.
Document Type:
Supplementary table
Database:
Ovid MEDLINE
Subject:
Cutaneous Lupus Erythematosus and plant-derived or antimalarial interventions
Content Type:
Search strategy
Medical Subject Headings (MeSH):
Lupus Erythematosus, Cutaneous; Plants; Plant Structures; Fungi; Bacteria; Herbal Medicine; Antimalarials; Artemisinins; Chloroquine; Quinidine; Quinine
Keywords Included:
botanical terms, herbal medicine, traditional Chinese medicine, Janus kinase inhibitors, antimalarial agents, specific plant genera and compounds
Search Fields:
Title and abstract (ti,ab)
Boolean Logic:
Combination of controlled vocabulary and keyword terms using AND/OR operators
Purpose:
Identification of relevant biomedical literature
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2010
Location:
Bethesda, Maryland, USA
Subject:
Systemic Lupus Erythematosus, Autoimmune Disease, Translational Research
Document type:
Conference Report
Organizers:
National Cancer Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Allergy and Infectious Diseases, Office of Research on Women’s Health, NIH
Collaborators:
Lupus Foundation of America, Inc.
Authors/Speakers:
Dr. Betty Diamond, Dr. Timothy Behrens, Dr. Howard Young, Dr. Silvia Bolland, Dr. Juan Rivera, Dr. Joe Craft, Dr. Mary Crow, Dr. David Close, Dr. Virginia Pascual, Dr. Mariana Kaplan
Conference dates:
September 2–3, 2010
Topics covered:
Interferon and innate responses, autoantibodies, lymphocyte activation, clinical challenges, genetic analysis of lupus, translational research from mouse models to human disease
Target audience:
Basic and clinical scientists, researchers in academia, industry, and government
Type of sessions:
Lectures, panel discussions, and research presentations
Research focus:
Mechanisms of lupus pathogenesis, type I interferon signature, B cell and T cell involvement, translational insights from mouse models, therapeutic development, clinical trials
Summary:
Conference proceedings detailing presentations and discussions on systemic lupus erythematosus, including translational studies from mouse models to human disease, mechanisms of immune dysregulation, and emerging therapies.
Year:
2013–2016
Region / City:
Belo Horizonte, Brazil
Topic:
Systemic Lupus Erythematosus, Endothelial Microparticles
Document Type:
Research Article
Institution:
Federal University of Minas Gerais, Santa Casa Hospital
Authors:
Walter B. Cicarini, Karine S. Ferreira, Cristina M.G. Loures, Renato V. Consoli, Cláudia L.S. Neiva, Paulo M. Pádua, Fernanda F.C. Nunes, Luan C.V. Alves, Edna A. Reis, Vicente P.C.P Toledo, Bashir A. Lwaleed, Maria G. Carvalho
Funding:
CNPq, CAPES, FAPEMIG
Study Design:
Cross-sectional
Participants:
90 women, including healthy volunteers and SLE patients with low and moderate/high disease activity
Methods:
Blood collection, ultracentrifugation, flow cytometry
Outcome Measures:
Endothelial microparticles levels, correlation with SLEDAI-2K Score and age
Ethical Approval:
Research Ethics Committee of the Federal University of Minas Gerais, Reference 01928412.8.0000.5149
Inclusion Criteria:
Women aged-matched, SLE diagnosis per ACR criteria 1997
Exclusion Criteria:
Other autoimmune diseases, anticoagulant use, pregnancy, immunosuppressive diseases
Treatment:
Azathioprine, Prednisone, Hydroxychloroquine
Corresponding Author:
Bashir A. Lwaleed, University of Southampton, UK
Note:
Year
Subject:
Thrombophilia testing, Lupus Anticoagulant screening
Document Type:
Medical form
Target Audience:
Medical team, requesting clinicians
Context:
Medical form for requesting thrombophilia and lupus anticoagulant testing, including details for genetic testing and sample collection.
Date:
August 29, 2025
Location:
Florence, South Carolina
Organization:
HopeHealth
Sponsor:
Bristol Myers Squibb
Type of document:
Press release
Subject:
Launch of Phase 3 clinical trial site for systemic lupus erythematosus (SLE)
Clinical trial phase:
Phase 3
Investigational medication:
Deucravacitinib
Principal investigator:
Supen Patel
Chief medical officer:
Edward Behling
Corporate representative:
Andrew Whitehead
Disease focus:
Systemic lupus erythematosus (SLE)
Geographic focus:
Rural South Carolina, Pee Dee region
Participating population:
Patients with systemic lupus erythematosus
Issuing contact:
Monica Hanna, [email protected]
Note:
, (843) 432-2959
Year:
2010
Location:
Bethesda, Maryland, USA
Subject:
Systemic Lupus Erythematosus, Autoimmune Disease, Translational Research
Document type:
Conference Report
Organizers:
National Cancer Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Allergy and Infectious Diseases, Office of Research on Women’s Health, NIH
Collaborators:
Lupus Foundation of America, Inc.
Authors/Speakers:
Dr. Betty Diamond, Dr. Timothy Behrens, Dr. Howard Young, Dr. Silvia Bolland, Dr. Juan Rivera, Dr. Joe Craft, Dr. Mary Crow, Dr. David Close, Dr. Virginia Pascual, Dr. Mariana Kaplan
Conference dates:
September 2–3, 2010
Topics covered:
Interferon and innate responses, autoantibodies, lymphocyte activation, clinical challenges, genetic analysis of lupus, translational research from mouse models to human disease
Target audience:
Basic and clinical scientists, researchers in academia, industry, and government
Type of sessions:
Lectures, panel discussions, and research presentations
Research focus:
Mechanisms of lupus pathogenesis, type I interferon signature, B cell and T cell involvement, translational insights from mouse models, therapeutic development, clinical trials
Summary:
Conference proceedings detailing presentations and discussions on systemic lupus erythematosus, including translational studies from mouse models to human disease, mechanisms of immune dysregulation, and emerging therapies.
Year:
2013–2016
Region / City:
Belo Horizonte, Brazil
Topic:
Systemic Lupus Erythematosus, Endothelial Microparticles
Document Type:
Research Article
Institution:
Federal University of Minas Gerais, Santa Casa Hospital
Authors:
Walter B. Cicarini, Karine S. Ferreira, Cristina M.G. Loures, Renato V. Consoli, Cláudia L.S. Neiva, Paulo M. Pádua, Fernanda F.C. Nunes, Luan C.V. Alves, Edna A. Reis, Vicente P.C.P Toledo, Bashir A. Lwaleed, Maria G. Carvalho
Funding:
CNPq, CAPES, FAPEMIG
Study Design:
Cross-sectional
Participants:
90 women, including healthy volunteers and SLE patients with low and moderate/high disease activity
Methods:
Blood collection, ultracentrifugation, flow cytometry
Outcome Measures:
Endothelial microparticles levels, correlation with SLEDAI-2K Score and age
Ethical Approval:
Research Ethics Committee of the Federal University of Minas Gerais, Reference 01928412.8.0000.5149
Inclusion Criteria:
Women aged-matched, SLE diagnosis per ACR criteria 1997
Exclusion Criteria:
Other autoimmune diseases, anticoagulant use, pregnancy, immunosuppressive diseases
Treatment:
Azathioprine, Prednisone, Hydroxychloroquine
Corresponding Author:
Bashir A. Lwaleed, University of Southampton, UK
Year:
2023
Field:
Biomedical materials / Wound healing
Document type:
Research data tables
Materials:
Cellulose, Chitosan, Ethyl cellulose, Carboxymethyl cellulose, Soy protein, Peanut protein isolate, Alginate, PVA, Silk Fibroin
Active compounds:
Curcumin, Gallic acid, Trilazad mesylate, Gentamycin, Silver sulfadiazine, Ciprofloxacin, Diclofenac sodium, Capsaicin, Tetracycline-hydrochloride, Dexpanthenol, VEGF, Arnebia Euchroma extract
Methodology:
Electrospinning, Drug loading and release assays, In vitro and In vivo testing
Applications:
Wound healing, Antibacterial activity, Cell proliferation, Angiogenesis
Target organisms:
Staphylococcus aureus, Escherichia coli, Bacillus subtilis, B16F10 melanoma cells
Experimental models:
Mouse skin wound models, Rat full-thickness wounds, Human keratinocyte cultures
Outcome measures:
Wound closure rate, Collagen deposition, Dermal regeneration, Cell adhesion and migration
Year:
2023
Region / Country:
India
Subject:
Aquaculture nutrition, plant-based fish feed
Document Type:
Review article
Institution / Organization:
Not specified
Author:
Not specified
Target Audience:
Researchers, aquaculture practitioners
Key Species:
Labeo rohita (rohu)
Feed Resources:
Sweet potato leaves, mustard oil cake, Delonix regia leaf meal, soybean, moringa, duckweed, cassava leaf meal
Focus:
Growth performance, health parameters, digestibility, enzyme activity, anti-nutritional factors, sustainability
Keywords:
Labeo rohita, plant-based aquafeed, growth, anti-nutritional factors, immune modulation, sustainability
Year:
2023
Region / City:
India
Subject:
Aquaculture, Sustainable feed alternatives, Plant-based nutrition
Document Type:
Review Article
Organization / Institution:
N/A
Author:
N/A
Target Audience:
Researchers, Aquaculture professionals
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A